MarketInOut Stock Screener Log In | Sign Up
 

Bukwang Pharmaceutical Co Ltd

KRX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 09/11/2026 15:30
Bukwang Pharmaceutical Co Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization403,538 mln
Float68.73 mln
Earnings Date07/23/2025

EPS

85.00
Exceptional

P / E

46.71
High premium

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-1.38
Manipulation likely

Relative Strength

21 / 100
Significantly lagging

Debt / Equity

0.24
Very low leverage

Business Description

Founded in 1960 and based in Seoul, Bukwang Pharmaceutical is a South Korean drug maker that sells a wide range of prescription medicines, over-the-counter products, and everyday health items such as vitamins, oral care goods, and dietary supplements, both at home and abroad. The company serves patients across many medical fields, from heart disease and cancer to digestive and mental health conditions. It is also advancing a pipeline of new treatments targeting schizophrenia, Parkinson's disease, prostate cancer, and other serious illnesses.

Key Fundamentals

EPS85.00
P/E46.71
ROE2.75
RPS2,194
ROIC4.39
ROA1.93
EBITDA, mln11,250
EV / EBITDA29.00
EV / EBIT41.99
Revenue, mln215,093
EV / Revenue1.52

Financial Strength

Altman Z-Score3.29
Piotroski F-Score 4 / 9
Beneish M-Score-1.38
Price to Intrinsic Value1.09
Price to Graham Number1.67
Shiller PE Ratio33.39

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.7% 23 / 100   
1 Month -12.17% 14 / 100   
2 Months -10.48% 46 / 100   
6 Months -25.93% 30 / 100   
1 Year 21.04% 74 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us